Myriad Women's Health provides the following resources in select languages:

Revolutionary New Technology

Raise the bar for NIPS in your practice.

EQUITY OF CARE FOR ALL PATIENTS

50% of pregnant patients present as high BMI to their OBGYN1. Many will be offered NIPS later in pregnancy or will be concerned about their result because of how a low fetal fraction sample may influence accuracy. This creates a disparity in care in pregnancy management.

Prequel™ with AMPLIFY™ technology raises NIPS performance most dramatically for the types of patients who have traditionally had low fetal fraction on standard NIPS due to high BMI or aneuploidy.

watch our recorded webinar

Learn more about Prequel with AMPLIFY Technology: the latest advancement in noninvasive prenatal screening (NIPS).

REVOLUTIONARY NEW TECHNOLOGY

3.9x amplification of fetal fraction in the traditionally difficult to call samples, originally coming in at below 4% fetal fraction.1

EVERYTHING JUST GOT BETTER

Now >99.9% of samples will present as >4% fetal fraction.1 

ONE TEST FOR ALL PATIENTS

An equity of care across all patient populations.

EVERYTHING JUST GOT BETTER WITH NIPS TECHNOLOGY

Learn more about Prequel with AMPLIFY technology.

Revolutionary Advancement in NIPS

Learn more from our research.

  1. Deputy, N.P., Dub, B. And Sharma, A. J. (2018). Prevalence and Trends in Prepregnancy Normal Weight – 48 States, New York City, and District of Columbia, 2011 – 2015, MMWR. Morbidity and morality weekly report, 66(51-52), pp. 1402-1407.
  2. Welker et al., 2020. Under peer review (preprint at https://www.medrxiv.org/content/10.1101/2020.07.12.20034926v1).